HSCS (STOCKS)
HeartSciences Inc. Common Stock
$2.050000
+0.050000 (+2.50%)
Prev close: $2.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Andrew Christopher Simpson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7.99M
- Employees
- 12
- P/E (TTM)
- -0.51
- P/B (TTM)
- 28.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q4)
|
$-0.87 | $-0.74 | -0.1254 | -16.84% |
|
Mar 2026 (Q3)
|
$-0.63 | $-0.87 | +0.2370 | +27.34% |
|
Dec 2025 (Q2)
|
$-0.85 | $-2.01 | +1.1645 | +57.81% |
|
Sep 2025 (Q1)
|
$-1.58 | $-1.94 | +0.3580 | +18.47% |
Financial Statements
| Revenues | $4.32K |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $1.77K |
| Costs And Expenses | $8.42M |
| Gross Profit | $2.55K |
| Nonoperating Income/Loss | -$729.01K |
| Operating Expenses | $8.42M |
| Selling, General, and Administrative Expenses | $5.58M |
| Research and Development | $2.84M |
| Operating Income/Loss | -$8.41M |
| Income/Loss From Continuing Operations After Tax | -$9.14M |
| Income/Loss From Continuing Operations Before Tax | $4.32K |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$9.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.48 |
| Basic Average Shares | 2,625,421 |
| Inventory | $655.63K |
| Fixed Assets | $39.31K |
| Liabilities | -$226.06K |
| Current Liabilities | -$226.06K |
| Noncurrent Liabilities | $0.00 |
| Equity | $226.06K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $226.06K |
| Net Cash Flow From Operating Activities | -$7.43M |
| Net Cash Flow From Operating Activities, Continuing | -$7.43M |
| Net Cash Flow From Investing Activities | -$44.45K |
| Net Cash Flow From Investing Activities, Continuing | -$44.45K |
| Net Cash Flow From Financing Activities | $8.03M |
| Net Cash Flow From Financing Activities, Continuing | $8.03M |
| Net Cash Flow | $558.72K |
| Net Cash Flow, Continuing | $558.72K |
| Comprehensive Income/Loss | -$9.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.14M |
| Other Comprehensive Income/Loss | $0.00 |